Literature DB >> 19554059

[Thrombosis in vascular accesses for haemodialysis: rescue treatment using invasive vascular radiological techniques].

J García Medina1, N Lacasa Pérez, S Muray Cases, I Pérez Garrido, V García Medina.   

Abstract

BACKGROUND: The purpose of this paper is to communicate our experience in the salvage of thrombosed haemodialysis vascular accesses using interventional radiology techniques.
METHODS: In the last four years, we have treated, by radiological means, 101 thrombosed haemodialysis vascular accesses. There were 44 autologous arteriovenous fistulas (43.56%) and 57 PTFE grafts (56.44%). There were 69 men (68.3%) and 32 women (31.7%). The mean age was 67.73 years (range 33-84). The mean vascular access age was 23.79 months (range 1-132). Manual catheter-directed aspiration was used. Fragmented, triturated or pushed the thrombus against the pulmonary circulation was avoided in all cases.
RESULTS: 78 accesses were salvaged (77.2%). Autologous fistulas average and PTFE grafts success rate were 84.44% and 71.42% respectively. Angioplasty in one or more lesions after thromboaspiration was performed in all accesses, except six (5.9%). Metallic endoprostheses were implanted in 14 accesses (13.9%). Mean follow-up was 9 months (range 0-44). Primary patency was 42.3% +/- 5 at 6 months and 32% +/- 4 at one year. Autologous fistulas patency was better than PTFE grafts patency (p < or =0,05).
CONCLUSIONS: Our results suggest thrombosed autologous arteriovenous fistulas salvage is better than PTFE grafts. This justifies interventional radiology techniques in these situations.

Entities:  

Mesh:

Year:  2009        PMID: 19554059     DOI: 10.3265/Nefrologia.2009.29.3.5014.en.full

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  1 in total

1.  The comparison of the complications of axillobrachial and femorofemoral arteriovenous shunt prostheses in hemodialysis, a 3 year study in Alzahra general hospital.

Authors:  Hafez Ghaheri; Mohamad Reza Lavasanijou; Ali Akbar Beigi; Afrooz Eshaghian; Mojtaba Akbari
Journal:  Adv Biomed Res       Date:  2013-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.